PD 153035

Known as: PD-153035, PD153035 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2018
051019942018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Post-extravasation survival is a key rate-limiting step of metastasis; however, not much is known about the factors that enable… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
Epidermal growth factor (EGF)-like ligands and their receptors constitute one of the most important signaling networks… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Epidermal growth factor receptor (EGFR) transactivation is a mediator of angiotensin II (Ang II) signaling in cultured… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2002
2002
The intracellular signals driving the proliferation of breast carcinoma (BC) cells have been widely studied. Both the mitotic and… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
We previously reported that expression of angiogenesis factors interleukin-8 (IL-8) and vascular endothelial growth factor (VEGF… (More)
Is this relevant?
2002
2002
We have recently shown that leukotriene D(4) (LTD(4)) increases cell survival in intestinal epithelial cells. Here we report and… (More)
Is this relevant?
2001
2001
In glioblastoma cells, inhibition of focal adhesion kinase (FAK) by the focal adhesion targeting domain attenuated epidermal… (More)
Is this relevant?
1998
1998
Signaling through the epidermal growth factor receptor (EGFR) has been primarily implicated in the growth of epithelial cells… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1996
1996
4-(3-Bromoanilino)-6,7-dimethoxyquinazoline (32, PD 153035) is a very potent inhibitor (IC50 0.025 nM) of the tyrosine kinase… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
A small molecule called PD 153035 inhibited the epidermal growth factor (EGF) receptor tyrosine kinase with a 5-pM inhibition… (More)
Is this relevant?